Data / Form D filings / Oncolix, Inc.
Oncolix, Inc.: Form D filings
Oncolix, Inc., a biotechnology company in Houston, TX, filed 7 Form D notices with the SEC between 2013 and 2017. The latest, on February 6, 2017, reports $250,000 sold of a $5 million offering to 1 investor.
Find out what Oncolix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14405 WALTERS ROAD, SUITE 780, Houston, TX, 77014
- Phone
- (281) 402-3169
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574061
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 6, 2017 | New notice | $5,000,000 | $250,000 | $4,750,000 | 1 | Jan 20, 2017 | sec.gov |
| Oct 25, 2016 | Amendment | $400,000 | $150,000 | $250,000 | 2 | Sep 13, 2016 | sec.gov |
| Oct 4, 2016 | New notice | $200,000 | $150,000 | $50,000 | 2 | Sep 13, 2016 | sec.gov |
| Jan 22, 2015 | New notice | $6,508,704 | $4,508,704 | $2,000,000 | 5 | Jan 16, 2015 | sec.gov |
| May 14, 2013 | New notice | $2,400,000 | $2,400,000 | $0 | 1 | Apr 24, 2012 | sec.gov |
| May 14, 2013 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Oct 10, 2011 | sec.gov |
| May 14, 2013 | New notice | $50,000 | $50,000 | $0 | 1 | Aug 17, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jerry T Youkey | Director | |
| Dale T Zajicek | Director | |
| Joseph T Podolski | Director | |
| Michael T Redman | Executive Officer, Director | |
| J Donald T Payne | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Feb 6, 2017 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Oncolix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.